APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthopedic Hyaluronic Acid Viscosupplementation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Orthopedic Hyaluronic Acid Viscosupplementation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchOrthopedic Hyaluronic Acid Viscosupplementation Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthopedic Hyaluronic Acid Viscosupplementation Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthopedic Hyaluronic Acid Viscosupplementation Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Orthopedic Hyaluronic Acid Viscosupplementation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation include Haohai Biological, Sanofi, Shanghai Jingfeng, Ferring, Zimmer Biomet, Seikagaku, LG Chem, Freda and Bioventus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orthopedic Hyaluronic Acid Viscosupplementation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orthopedic Hyaluronic Acid Viscosupplementation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orthopedic Hyaluronic Acid Viscosupplementation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orthopedic Hyaluronic Acid Viscosupplementation market size, projected growth trends, production technologies, key applications, and end-use industries.

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Company

Haohai Biological

Sanofi

Shanghai Jingfeng

Ferring

Zimmer Biomet

Seikagaku

LG Chem

Freda

Bioventus

Anika Therapeutics

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Type

Five Injection

Three Injection

Single Injection

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Application

Hospitals

Clinics

Others

Orthopedic Hyaluronic Acid Viscosupplementation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Hyaluronic Acid Viscosupplementation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthopedic Hyaluronic Acid Viscosupplementation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthopedic Hyaluronic Acid Viscosupplementation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orthopedic Hyaluronic Acid Viscosupplementation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orthopedic Hyaluronic Acid Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Orthopedic Hyaluronic Acid Viscosupplementation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Orthopedic Hyaluronic Acid Viscosupplementation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends Table 2. Orthopedic Hyaluronic Acid Viscosupplementation Industry Drivers Table 3. Orthopedic Hyaluronic Acid Viscosupplementation Industry Opportunities and Challenges Table 4. Orthopedic Hyaluronic Acid Viscosupplementation Industry Restraints Table 5. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Manufacturers Table 9. Global Orthopedic Hyaluronic Acid Viscosupplementation Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Orthopedic Hyaluronic Acid Viscosupplementation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Orthopedic Hyaluronic Acid Viscosupplementation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Orthopedic Hyaluronic Acid Viscosupplementation Manufacturers, Product Type & Application Table 13. Global Orthopedic Hyaluronic Acid Viscosupplementation Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Orthopedic Hyaluronic Acid Viscosupplementation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Five Injection Table 17. Major Manufacturers of Three Injection Table 18. Major Manufacturers of Single Injection Table 19. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021-2026) & (k units) Table 21. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2027-2032) & (k units) Table 22. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2021-2026) Table 23. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2027-2032) Table 24. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2021-2026) & (k units) Table 26. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2027-2032) & (k units) Table 27. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2021-2026) Table 28. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021-2026) & (k units) Table 34. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2027-2032) & (k units) Table 35. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2021-2026) Table 36. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2027-2032) Table 37. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2021-2026) & (k units) Table 39. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2027-2032) & (k units) Table 40. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2021-2026) Table 41. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2027-2032) Table 42. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2021-2026) & (k units) Table 44. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Region (2021-2026) Table 45. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026) & (k units) Table 49. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032) & (k units) Table 50. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026) & (k units) Table 52. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2027-2032) & (k units) Table 59. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Region (2021-2026) Table 63. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Region (2027-2032) Table 64. Haohai Biological Company Information Table 65. Haohai Biological Business Overview Table 66. Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 68. Haohai Biological Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 73. Sanofi Recent Development Table 74. Shanghai Jingfeng Company Information Table 75. Shanghai Jingfeng Business Overview Table 76. Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 78. Shanghai Jingfeng Recent Development Table 79. Ferring Company Information Table 80. Ferring Business Overview Table 81. Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 83. Ferring Recent Development Table 84. Zimmer Biomet Company Information Table 85. Zimmer Biomet Business Overview Table 86. Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 88. Zimmer Biomet Recent Development Table 89. Seikagaku Company Information Table 90. Seikagaku Business Overview Table 91. Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 93. Seikagaku Recent Development Table 94. LG Chem Company Information Table 95. LG Chem Business Overview Table 96. LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 98. LG Chem Recent Development Table 99. Freda Company Information Table 100. Freda Business Overview Table 101. Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 103. Freda Recent Development Table 104. Bioventus Company Information Table 105. Bioventus Business Overview Table 106. Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 108. Bioventus Recent Development Table 109. Anika Therapeutics Company Information Table 110. Anika Therapeutics Business Overview Table 111. Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio Table 113. Anika Therapeutics Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Orthopedic Hyaluronic Acid Viscosupplementation Distributors List Table 117. Orthopedic Hyaluronic Acid Viscosupplementation Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Orthopedic Hyaluronic Acid Viscosupplementation Product Image Figure 2. Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size (2021-2032) & (US$ Million) Figure 4. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales (2021-2032) & (k units) Figure 5. Global Orthopedic Hyaluronic Acid Viscosupplementation Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Orthopedic Hyaluronic Acid Viscosupplementation Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Five Injection Image Figure 9. Three Injection Image Figure 10. Single Injection Image Figure 11. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2021-2032) Figure 14. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2021-2032) Figure 23. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2021-2032) Figure 26. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2021-2032) Figure 28. U.S. Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2021-2032) Figure 33. Germany Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2021-2032) Figure 40. China Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Country (2021-2032) Figure 48. Brazil Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Orthopedic Hyaluronic Acid Viscosupplementation Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032) & (US$ Million) Figure 59. North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032) & (US$ Million) Figure 61. Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Orthopedic Hyaluronic Acid Viscosupplementation Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Orthopedic Hyaluronic Acid Viscosupplementation Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Five Injection
  • Three Injection
  • Single Injection
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Haohai Biological
  • Sanofi
  • Shanghai Jingfeng
  • Ferring
  • Zimmer Biomet
  • Seikagaku
  • LG Chem
  • Freda
  • Bioventus
  • Anika Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Dynamics
  1. 2.1 Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends
  2. 2.2 Orthopedic Hyaluronic Acid Viscosupplementation Industry Drivers
  3. 2.3 Orthopedic Hyaluronic Acid Viscosupplementation Industry Opportunities and Challenges
  4. 2.4 Orthopedic Hyaluronic Acid Viscosupplementation Industry Restraints
3 Orthopedic Hyaluronic Acid Viscosupplementation Market by Manufacturers
  1. 3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Manufacturers (2021-2026)
  3. 3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orthopedic Hyaluronic Acid Viscosupplementation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Orthopedic Hyaluronic Acid Viscosupplementation Manufacturers, Product Type & Application
  7. 3.7 Global Orthopedic Hyaluronic Acid Viscosupplementation Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orthopedic Hyaluronic Acid Viscosupplementation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orthopedic Hyaluronic Acid Viscosupplementation Tier 1, Tier 2, and Tier 3
4 Orthopedic Hyaluronic Acid Viscosupplementation Market by Type
  1. 4.1 Orthopedic Hyaluronic Acid Viscosupplementation Type Introduction
  2. 4.1.1 Five Injection
  3. 4.1.2 Three Injection
  4. 4.1.3 Single Injection
  5. 4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type
  6. 4.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021-2032)
  8. 4.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2021-2032)
  9. 4.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type
  10. 4.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2021-2032)
  12. 4.3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2021-2032)
5 Orthopedic Hyaluronic Acid Viscosupplementation Market by Application
  1. 5.1 Orthopedic Hyaluronic Acid Viscosupplementation Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application
  6. 5.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021-2032)
  8. 5.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2021-2032)
  9. 5.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application
  10. 5.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2021-2032)
  12. 5.3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2021-2032)
6 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region
  1. 6.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2021-2032)
  3. 6.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region (2021-2026)
  4. 6.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region
  1. 7.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region
  2. 7.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region (2021-2026)
  4. 7.1.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region (2027-2032)
  5. 7.1.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032)
  8. 7.2.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032)
  11. 7.3.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Haohai Biological
  2. 8.1.1 Haohai Biological Company Information
  3. 8.1.2 Haohai Biological Business Overview
  4. 8.1.3 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  6. 8.1.5 Haohai Biological Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Shanghai Jingfeng
  14. 8.3.1 Shanghai Jingfeng Company Information
  15. 8.3.2 Shanghai Jingfeng Business Overview
  16. 8.3.3 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  18. 8.3.5 Shanghai Jingfeng Recent Developments
  19. 8.4 Ferring
  20. 8.4.1 Ferring Company Information
  21. 8.4.2 Ferring Business Overview
  22. 8.4.3 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  24. 8.4.5 Ferring Recent Developments
  25. 8.5 Zimmer Biomet
  26. 8.5.1 Zimmer Biomet Company Information
  27. 8.5.2 Zimmer Biomet Business Overview
  28. 8.5.3 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  30. 8.5.5 Zimmer Biomet Recent Developments
  31. 8.6 Seikagaku
  32. 8.6.1 Seikagaku Company Information
  33. 8.6.2 Seikagaku Business Overview
  34. 8.6.3 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  36. 8.6.5 Seikagaku Recent Developments
  37. 8.7 LG Chem
  38. 8.7.1 LG Chem Company Information
  39. 8.7.2 LG Chem Business Overview
  40. 8.7.3 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  42. 8.7.5 LG Chem Recent Developments
  43. 8.8 Freda
  44. 8.8.1 Freda Company Information
  45. 8.8.2 Freda Business Overview
  46. 8.8.3 Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  48. 8.8.5 Freda Recent Developments
  49. 8.9 Bioventus
  50. 8.9.1 Bioventus Company Information
  51. 8.9.2 Bioventus Business Overview
  52. 8.9.3 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  54. 8.9.5 Bioventus Recent Developments
  55. 8.10 Anika Therapeutics
  56. 8.10.1 Anika Therapeutics Company Information
  57. 8.10.2 Anika Therapeutics Business Overview
  58. 8.10.3 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
  60. 8.10.5 Anika Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orthopedic Hyaluronic Acid Viscosupplementation Value Chain Analysis
  2. 9.1.1 Orthopedic Hyaluronic Acid Viscosupplementation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orthopedic Hyaluronic Acid Viscosupplementation Production Mode & Process
  6. 9.2 Orthopedic Hyaluronic Acid Viscosupplementation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orthopedic Hyaluronic Acid Viscosupplementation Distributors
  9. 9.2.3 Orthopedic Hyaluronic Acid Viscosupplementation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst